Ignite Creation Date:
2025-12-25 @ 2:03 AM
Ignite Modification Date:
2026-02-25 @ 5:54 PM
Study NCT ID:
NCT02249260
Status:
UNKNOWN
Last Update Posted:
2014-09-25
First Post:
2014-08-26
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Prospective Cohort Study of Heart Patients Included in Exercise Based Rehabilitation in Oslo
Sponsor:
Oslo University Hospital
Organization:
Study Overview
Official Title:
Long-term Follow up of Exercise Based Cardiac Rehabilitation in Oslo
Status:
UNKNOWN
Status Verified Date:
2014-09
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
OsloHeartEx
Brief Summary:
Outcomes evaluation is a critical component in outpatient cardiac rehabilitation. The aim of this study is to examine factors who predict long-term effects of improved peak oxygen uptake one year after participating in cardiac rehabilitation.
Secondary to evaluate the short and long-term outcome of a 12-week outpatient cardiac rehabilitation program.
Secondary to evaluate the short and long-term outcome of a 12-week outpatient cardiac rehabilitation program.
Detailed Description:
A prospective cohort study including all cardiac patients referred for outpatient cardiac rehabilitation in a primary care clinic in Oslo. The main efficacy variable is the changes in exercise capacity (VO2peak) as a primary prognostic measure of successful rehabilitation. HRQoL are measured by self-report using the COOP/WONCA questionnaire and SF-36.
Study Oversight
Has Oversight DMC:
True
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: